InnoCan Pharma Corporation
InnoCan Pharma Corporation
Indice CSE:
CSE CompositeDevise:
CAD The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.
InnoCan Pharma Corporation (INNO)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Information d'entreprise
Addresse
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
CanadaTéléphone
403-777-1519Courriel
irisb@innocanpharma.comURL
http://innocanpharma.comDate d’inscription à la cote
Mardi, septembre 24, 2019
Agent de transfert
Odyssey Trust CompanySEDAR Information
Type de dossier
Tout
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
1015, 926 - 5 Avenue SW
Calgary, AB T2P 0N7
CanadaTéléphone
403-777-1519Courriel
irisb@innocanpharma.comURL
http://innocanpharma.comDate d’inscription à la cote
Mardi, septembre 24, 2019
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
286938271Réservé à l'émission:
24346374Communiqués de presse
